Tower Research Capital LLC (Trc) Clearside Biomedical, Inc. Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 15,898 shares of CLSD stock, worth $16,215. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,898

Previous 7,897 101.32%

Holding current value

$16,215

Previous $12,000 66.67%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.08 - $1.58 $8,641 - $12,641	8,001 Added 101.32%	15,898 $20,000
Q1 2024 May 15, 2024	SELL	$1.2 - $2.02 $7,338 - $12,352	-6,115 Reduced 43.64%	7,897 $12,000
Q4 2023 Feb 13, 2024	BUY	$0.68 - $1.18 $2,159 - $3,747	3,176 Added 29.31%	14,012 $16,000
Q3 2023 Nov 14, 2023	BUY	$0.82 - $1.27 $8,885 - $13,761	10,836 New	10,836 $9,000
Q1 2023 May 09, 2023	BUY	$0.93 - $1.66 $59 - $106	64 New	64 $0
Q3 2022 Nov 10, 2022	BUY	$1.08 - $1.83 $1,904 - $3,226	1,763 Added 260.41%	2,440 $2,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.49 $9,934 - $19,028	-7,642 Reduced 91.86%	677 $1,000
Q1 2022 May 12, 2022	SELL	$1.35 - $2.88 $5,826 - $12,430	-4,316 Reduced 34.16%	8,319 $19,000
Q4 2021 Feb 14, 2022	BUY	$2.72 - $5.72 $26,351 - $55,415	9,688 Added 328.74%	12,635 $35,000
Q3 2021 Nov 15, 2021	BUY	$4.83 - $7.2 $14,234 - $21,218	2,947 New	2,947 $18,000
Q2 2021 Aug 16, 2021	SELL	$2.32 - $5.38 $38,679 - $89,695	-16,672 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.24 - $4.25 $26,754 - $50,762	11,944 Added 252.62%	16,672 $41,000
Q4 2020 Feb 16, 2021	SELL	$1.32 - $2.74 $10,222 - $21,218	-7,744 Reduced 62.09%	4,728 $13,000
Q3 2020 Nov 16, 2020	BUY	$1.45 - $2.0 $16,460 - $22,704	11,352 Added 1013.57%	12,472 $19,000
Q2 2020 Aug 13, 2020	BUY	$1.55 - $2.41 $1,736 - $2,699	1,120 New	1,120 $2,000
Q3 2019 Nov 05, 2019	SELL	$0.59 - $1.32 $4,555 - $10,193	-7,722 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$0.97 - $1.42 $6,643 - $9,725	6,849 Added 784.54%	7,722 $8,000
Q1 2019 May 14, 2019	SELL	$1.1 - $1.74 $4,296 - $6,796	-3,906 Reduced 81.73%	873 $1,000
Q4 2018 Feb 14, 2019	BUY	$1.0 - $6.12 $2,988 - $18,286	2,988 Added 166.83%	4,779 $5,000
Q3 2018 Nov 13, 2018	SELL	$6.03 - $11.24 $32,459 - $60,504	-5,383 Reduced 75.03%	1,791 $11,000
Q2 2018 Aug 15, 2018	SELL	$8.91 - $14.54 $44,558 - $72,714	-5,001 Reduced 41.08%	7,174 $77,000
Q1 2018 May 15, 2018	BUY	$5.57 - $14.28 $67,814 - $173,859	12,175 New	12,175 $130,000
Q4 2017 Feb 09, 2018	SELL	$5.78 - $9.12 $15,999 - $25,244	-2,768 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$6.73 - $8.74 $18,628 - $24,192	2,768	2,768 $24,000

Others Institutions Holding CLSD

# of Institutions

Shares Held

13.4M

Call Options Held

17.6K

Put Options Held

100

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Clearside Biomedical, Inc. Transaction History